The Janus kinases (Jaks)

被引:505
作者
Yamaoka, K
Saharinen, P
Pesu, M
Holt, VET
Silvennoinen, O
O'Shea, JJ [1 ]
机构
[1] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Helsinki, Biomedicum Helsinki, Mol & Canc Biol Lab, FIN-00014 Helsinki, Finland
[3] Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland
[4] Tampere Univ Hosp, Dept Clin Microbiol, FIN-33014 Tampere, Finland
关键词
D O I
10.1186/gb-2004-5-12-253
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The Janus kinase (Jak) family is one of ten recognized families of non-receptor tyrosine kinases. Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2). Birds, fish and insects also have Jaks. Each protein has a kinase domain and a catalytically inactive pseudo-kinase domain, and they each bind cytokine receptors through amino-terminal FERM (Band-4.1, ezrin, radixin, moesin) domains. Upon binding of cytokines to their receptors, Jaks are activated and phosphorylate the receptors, creating docking sites for signaling molecules, especially members of the signal transducer and activator of transcription (Stat) family. Mutations of the Drosophila Jak ( Hopscotch) have revealed developmental defects, and constitutive activation of Jaks in flies and humans is associated with leukemia-like syndromes. Through the generation of Jak-deficient cell lines and gene-targeted mice, the essential, nonredundant functions of Jaks in cytokine signaling have been established. Importantly, deficiency of Jak3 is the basis of human autosomal recessive severe combined immunodeficiency ( SCID); accordingly, a selective Jak3 inhibitor has been developed, forming a new class of immunosuppressive drugs.
引用
收藏
页数:6
相关论文
共 56 条
  • [21] Partial impairment of cytokine responses in Tyk2-deficient mice
    Karaghiosoff, M
    Neubauer, H
    Lassnig, C
    Kovarik, P
    Schindler, H
    Pircher, H
    McCoy, B
    Bogdan, C
    Decker, T
    Brem, G
    Pfeffer, K
    Müller, M
    [J]. IMMUNITY, 2000, 13 (04) : 549 - 560
  • [22] Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
    Karaghiosoff, M
    Steinborn, R
    Kovarik, P
    Kriegshäuser, G
    Baccarini, M
    Donabauer, B
    Reichart, U
    Kolbe, T
    Bogdan, C
    Leanderson, T
    Levy, D
    Decker, T
    Müller, M
    [J]. NATURE IMMUNOLOGY, 2003, 4 (05) : 471 - 477
  • [23] MOLECULAR-CLONING OF L-JAK, A JANUS FAMILY PROTEIN-TYROSINE KINASE EXPRESSED IN NATURAL-KILLER-CELLS AND ACTIVATED LEUKOCYTES
    KAWAMURA, M
    MCVICAR, DW
    JOHNSTON, JA
    BLAKE, TB
    CHEN, YQ
    LAL, BK
    LLOYD, AR
    KELVIN, DJ
    STAPLES, JE
    ORTALDO, JR
    OSHEA, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) : 6374 - 6378
  • [24] KROLEWSKI JJ, 1990, ONCOGENE, V5, P277
  • [25] Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-Bβ
    Kurzer, JH
    Argetsinger, LS
    Zhou, YJ
    Kouadio, JL
    O'Shea, JJ
    Carter-Su, C
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (10) : 4557 - 4570
  • [26] A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
    Lacronique, V
    Boureux, A
    DellaValle, V
    Poirel, H
    Quang, CT
    Mauchauffe, M
    Berthou, C
    Lessard, M
    Berger, R
    Ghysdael, J
    Bernard, OA
    [J]. SCIENCE, 1997, 278 (5341) : 1309 - 1312
  • [27] The Drosophila Jak kinase hopscotch is required for multiple developmental processes in the eye
    Luo, H
    Asha, H
    Kockel, L
    Parke, T
    Mlodzik, M
    Dearolf, CR
    [J]. DEVELOPMENTAL BIOLOGY, 1999, 213 (02) : 432 - 441
  • [28] MUTATIONS OF JAK-3 GENE IN PATIENTS WITH AUTOSOMAL SEVERE COMBINED IMMUNE-DEFICIENCY (SCID)
    MACCHI, P
    VILLA, A
    GILIANI, S
    SACCO, MG
    FRATTINI, A
    PORTA, F
    UGAZIO, AG
    JOHNSTON, JA
    CANDOTTI, F
    O'SHEA, JJ
    VEZZONI, P
    NOTARANGELO, LD
    [J]. NATURE, 1995, 377 (6544) : 65 - 68
  • [29] The protein kinase complement of the human genome
    Manning, G
    Whyte, DB
    Martinez, R
    Hunter, T
    Sudarsanam, S
    [J]. SCIENCE, 2002, 298 (5600) : 1912 - +
  • [30] CONSTITUTIVELY ACTIVATED JAK-STAT PATHWAY IN T-CELLS TRANSFORMED WITH HTLV-I
    MIGONE, TS
    LIN, JX
    CERESETO, A
    MULLOY, JC
    O'SHEA, JJ
    FRANCHINI, G
    LEONARD, WJ
    [J]. SCIENCE, 1995, 269 (5220) : 79 - 81